Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1995
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2004 2
2013 2
2014 2
2015 1
2016 1
2017 3
2019 2
2020 1
2021 3
2022 3
2023 2
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Familial Hypercholesterolemia and Its Current Diagnostics and Treatment Possibilities: A Literature Analysis.
Zubielienė K, Valterytė G, Jonaitienė N, Žaliaduonytė D, Zabiela V. Zubielienė K, et al. Medicina (Kaunas). 2022 Nov 17;58(11):1665. doi: 10.3390/medicina58111665. Medicina (Kaunas). 2022. PMID: 36422206 Free PMC article. Review.
Familial hypercholesterolemia (FH) is a common, inherited disorder of cholesterol metabolism. This pathology is usually an autosomal dominant disorder and is caused by inherited mutations in the APOB, LDLR, and PCSK9 genes. Patients can have a homozygous or a hetero …
Familial hypercholesterolemia (FH) is a common, inherited disorder of cholesterol metabolism. This pathology is usually an autosomal
Familial hypercholesterolemia and its manifestations: Practical considerations for general practitioners.
Anagnostis P, Antza C, Florentin M, Kotsis V. Anagnostis P, et al. Kardiol Pol. 2023;81(11):1081-1088. doi: 10.33963/v.kp.97845. Epub 2023 Nov 8. Kardiol Pol. 2023. PMID: 37937357 Free article. Review.
Familial hypercholesterolemia (FH) is the most common genetic disorder of lipid metabolism, affecting almost 1 in 250 individuals worldwide. It is usually inherited via the autosomal dominant way and is characterized by aberrantly high total and low-density l …
Familial hypercholesterolemia (FH) is the most common genetic disorder of lipid metabolism, affecting almost 1 in 250 individuals wor …
Endothelial dysfunction and angiogenesis in autosomal dominant polycystic kidney disease.
Fick-Brosnahan GM. Fick-Brosnahan GM. Curr Hypertens Rev. 2013 Feb;9(1):32-6. doi: 10.2174/1573402111309010006. Curr Hypertens Rev. 2013. PMID: 23971642 Review.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common potentially lethal hereditary disease. The hall mark of the disease is the development of innumerable cysts in kidneys and liver. However, a vascular phenotype including the
Autosomal dominant polycystic kidney disease (ADPKD) is the most common potentially lethal hereditary disease. T
Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy.
Koopal C, Marais AD, Westerink J, Visseren FL. Koopal C, et al. J Clin Lipidol. 2017 Jan-Feb;11(1):12-23.e1. doi: 10.1016/j.jacl.2016.10.001. Epub 2016 Oct 13. J Clin Lipidol. 2017. PMID: 28391878 Review.
Familial dysbetalipoproteinemia (FD) is a genetic disorder of lipoprotein metabolism associated with an increased risk for premature cardiovascular disease. In about 10% of the cases, FD is caused by autosomal dominant mutations in the apolipoprotein E gene ( …
Familial dysbetalipoproteinemia (FD) is a genetic disorder of lipoprotein metabolism associated with an increased risk for premature cardiov …
Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia.
Anagnostis P, Vaitsi K, Mintziori G, Goulis DG, Mikhailidis DP. Anagnostis P, et al. Curr Med Res Opin. 2020 May;36(5):731-740. doi: 10.1080/03007995.2020.1734783. Epub 2020 Mar 9. Curr Med Res Opin. 2020. PMID: 32096673 Review.
Objective: Familial hypercholesterolaemia (FH) is a common autosomal dominant inherited disease, affecting 1 in 200-500 individuals worldwide. FH is characterized by elevated circulating low-density lipoprotein cholesterol (LDL-C) concentrations. Its a …
Objective: Familial hypercholesterolaemia (FH) is a common autosomal dominant inherited disease, affecting 1 in …
LDL-receptor mutations in Europe.
Dedoussis GV, Schmidt H, Genschel J. Dedoussis GV, et al. Hum Mutat. 2004 Dec;24(6):443-59. doi: 10.1002/humu.20105. Hum Mutat. 2004. PMID: 15523646 Review.
Familial hypercholesterolemia (FH) is a clinical definition for a remarkable increase of cholesterol serum concentration, presence of xanthomas, and an autosomal dominant trait of either increased serum cholesterol or premature coronary artery disea
Familial hypercholesterolemia (FH) is a clinical definition for a remarkable increase of cholesterol serum concentration, presence of xantho …
Statins for children with familial hypercholesterolemia.
Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E, Ramaswami U. Vuorio A, et al. Cochrane Database Syst Rev. 2017 Jul 7;7(7):CD006401. doi: 10.1002/14651858.CD006401.pub4. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 Nov 7;2019(11). doi: 10.1002/14651858.CD006401.pub5 PMID: 28685504 Free PMC article. Updated. Review.
BACKGROUND: Familial hypercholesterolemia is one of the most common inherited metabolic diseases and is an autosomal dominant disorder meaning heterozygotes, or carriers, are affected. Those who are homozygous have severe disease. The average worldwide preval …
BACKGROUND: Familial hypercholesterolemia is one of the most common inherited metabolic diseases and is an autosomal dominant
Statins for children with familial hypercholesterolemia.
Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E, Ramaswami U. Vuorio A, et al. Cochrane Database Syst Rev. 2019 Nov 7;2019(11):CD006401. doi: 10.1002/14651858.CD006401.pub5. Cochrane Database Syst Rev. 2019. PMID: 31696945 Free PMC article.
BACKGROUND: Familial hypercholesterolemia is one of the most common inherited metabolic diseases and is an autosomal dominant disorder meaning heterozygotes, or carriers, are affected. Those who are homozygous have severe disease. The average worldwide preval …
BACKGROUND: Familial hypercholesterolemia is one of the most common inherited metabolic diseases and is an autosomal dominant
Aortic valve and arterial calcification in patients with familial hypercholesterolemia.
Waluś-Miarka M, Polus A, Idzior-Waluś B. Waluś-Miarka M, et al. Kardiol Pol. 2024;82(2):144-155. doi: 10.33963/v.phj.98945. Epub 2024 Feb 13. Kardiol Pol. 2024. PMID: 38348620 Free article. Review.
Heterozygous familial hypercholesterolemia (heFH) is an autosomal dominant lipid metabolism disorder. Its prevalence is 1:250-1:300 people in the population. Patients with heFH have an up to 13-fold increased risk of premature coronary artery
Heterozygous familial hypercholesterolemia (heFH) is an autosomal dominant lipid metabolism disorder. Its prevalence is 1
22 results